id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-11-24 12:16:43
expired found date
-
created at
2024-06-06 07:15:15
updated at
2025-12-29 04:59:10
length
17
crc
14795
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
103679
mp size raw text
7373
mp inner links count
1
mp inner links status
20 (imported)
title
SpringWorks Therapeutics - Unlocking Targeted Oncology
description
We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard, and act with urgency. %
image
site name
Springworks
author
updated
2025-12-16 21:28:49
raw text
SpringWorks Therapeutics - Unlocking Targeted Oncology Skip to content Menu Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information SEC Filings Annual Reports Stock Information Stock Quote & Chart Analyst Coverage Investor Resources Investor FAQs Investor Contacts Email Alerts Contact Us Linkedin Twitter Youtube Menu Who We Are Leadership & Board Mission & Values DE&I Partners & Collaborators Focus Areas Rare Oncology BCMA Combinations in Multiple Myeloma Biomarker-Defined Metastatic Solid Tumors Pipeline Overview Nirogacestat Mirdametinib Investigator-Initiated Research Medical Education & Grants Key Scientific Presentations and Publications Patients Desmoid Tumors NF1-PN Clinical Trials DeFi Trial ReNeu Trial Expanded Access Careers Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information SEC Filings...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
5737
text words
1021
text unique words
432
text lines
165
text sentences
45
text paragraphs
14
text words per sentence
22
text matched phrases
15
text matched dictionaries
5
links self subdomains
0
links other subdomains
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-16 21:28:49
rss path
rss status
32 (unknown)
rss found date
2023-12-28 09:03:55
rss size orig
677
rss items
0
rss spam phrases
0
rss detected language
126 (language undetectable (empty document, too short, or engines disagree))
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
1
sitemap urls count
38
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-01-01 11:03:53
sitemap process date
2024-10-29 00:09:51
sitemap first import date
-
sitemap last import date
-